Elanco Animal Health Inc (ELAN)
14.04
-0.16
(-1.09%)
USD |
NYSE |
Nov 14, 13:35
Elanco Animal Health Price: 14.04 for Nov. 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 14.20 | 14.32 | 14.13 | 14.19 | 3.458M |
Nov 12, 2024 | 14.08 | 14.71 | 14.02 | 14.12 | 3.947M |
Nov 11, 2024 | 14.12 | 14.44 | 14.02 | 14.27 | 3.246M |
Nov 08, 2024 | 14.28 | 14.40 | 13.84 | 14.07 | 6.324M |
Nov 07, 2024 | 13.20 | 14.75 | 12.87 | 14.50 | 9.246M |
Nov 06, 2024 | 12.82 | 13.10 | 12.64 | 12.86 | 9.503M |
Nov 05, 2024 | 12.45 | 12.77 | 12.35 | 12.67 | 2.896M |
Nov 04, 2024 | 12.60 | 12.83 | 12.50 | 12.56 | 3.257M |
Nov 01, 2024 | 12.60 | 12.75 | 12.50 | 12.60 | 3.804M |
Oct 31, 2024 | 12.70 | 12.79 | 12.42 | 12.64 | 8.819M |
Oct 30, 2024 | 12.49 | 12.78 | 12.46 | 12.78 | 4.545M |
Oct 29, 2024 | 12.47 | 12.62 | 12.40 | 12.51 | 2.879M |
Oct 28, 2024 | 12.49 | 12.63 | 12.41 | 12.51 | 3.051M |
Oct 25, 2024 | 12.35 | 12.47 | 12.18 | 12.41 | 2.839M |
Oct 24, 2024 | 12.43 | 12.66 | 12.34 | 12.39 | 3.063M |
Oct 23, 2024 | 12.66 | 12.69 | 12.32 | 12.51 | 3.700M |
Oct 22, 2024 | 12.46 | 12.68 | 12.27 | 12.66 | 3.921M |
Oct 21, 2024 | 12.97 | 13.16 | 12.62 | 12.62 | 3.649M |
Oct 18, 2024 | 12.77 | 13.19 | 12.71 | 12.97 | 4.801M |
Oct 17, 2024 | 13.21 | 13.21 | 12.75 | 12.83 | 6.578M |
Oct 16, 2024 | 13.83 | 13.96 | 13.10 | 13.26 | 8.990M |
Oct 15, 2024 | 14.24 | 14.46 | 13.94 | 13.95 | 3.157M |
Oct 14, 2024 | 14.42 | 14.50 | 14.21 | 14.37 | 2.831M |
Oct 11, 2024 | 14.48 | 14.66 | 14.31 | 14.37 | 2.801M |
Oct 10, 2024 | 14.50 | 14.76 | 14.42 | 14.52 | 2.979M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.08
Minimum
May 30 2023
36.72
Maximum
Aug 03 2021
21.22
Average
20.69
Median
Jul 07 2022
Price Benchmarks
Baxter International Inc | 32.02 |
Edwards Lifesciences Corp | 66.96 |
Syros Pharmaceuticals Inc | 0.2901 |
Opus Genetics Inc | 1.08 |
Edgewise Therapeutics Inc | 32.87 |
Price Related Metrics
PE Ratio | 35.09 |
PS Ratio | 1.560 |
Price to Book Value | 1.064 |
Price to Free Cash Flow | 18.68 |
Earnings Yield | 2.85% |
Market Cap | 6.938B |
Operating PE Ratio | 27.47 |